Latest news with #Kneat
Business Upturn
26-06-2025
- Business
- Business Upturn
Global Healthcare Technology Leader Selects Kneat
LIMERICK, Ireland, June 26, 2025 (GLOBE NEWSWIRE) — inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading healthcare technology and diagnostics company ('the Company') has signed a multi-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, employs over 50,000 people and manufactures in more than a dozen countries worldwide. This manufacturer of medical technology, including medical devices and pharmaceutical diagnostics, will use the Kneat Gx platform initially to digitize its Commissioning, Qualification and Validation workflows for facilities, equipment and computer systems at several lead manufacturing sites. 'After an extensive evaluation process this global leader selected Kneat to drive efficiency, quality and compliance through greater digitalization of their Validation processes,' said Eddie Ryan, Kneat CEO. 'I'm happy that Kneat will be supporting both new builds and ongoing operations where we are proven to deliver significant business value.' The steady pace of Kneat's strategic customer wins indicates that digital validation is progressively becoming the norm for life sciences companies. The State of Validation 2025 study also supports this trend. The total percentage of organizations surveyed that are either using or planning to use digital validation is now 93 percent, versus 86 percent in the 2024 study. The shift is unsurprising. Done right, digital validation delivers speed to market; trustworthy, scalable compliance; and a foundation to leverage integrated automation and AI-driven innovations in the future. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. Cautionary and Forward-Looking Statements Except for the statements of historical fact contained herein, certain information presented constitutes 'forward-looking information' within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, and the compliance of Kneat's platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties. Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor's own risk. For more information visit Contact: Katie Keita, Kneat Investor RelationsP: + 1 902-450-2660 E: [email protected]
Yahoo
26-06-2025
- Business
- Yahoo
Global Healthcare Technology Leader Selects Kneat
LIMERICK, Ireland, June 26, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading healthcare technology and diagnostics company ('the Company') has signed a multi-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, employs over 50,000 people and manufactures in more than a dozen countries worldwide. This manufacturer of medical technology, including medical devices and pharmaceutical diagnostics, will use the Kneat Gx platform initially to digitize its Commissioning, Qualification and Validation workflows for facilities, equipment and computer systems at several lead manufacturing sites. "After an extensive evaluation process this global leader selected Kneat to drive efficiency, quality and compliance through greater digitalization of their Validation processes,' said Eddie Ryan, Kneat CEO. 'I'm happy that Kneat will be supporting both new builds and ongoing operations where we are proven to deliver significant business value.' The steady pace of Kneat's strategic customer wins indicates that digital validation is progressively becoming the norm for life sciences companies. The State of Validation 2025 study also supports this trend. The total percentage of organizations surveyed that are either using or planning to use digital validation is now 93 percent, versus 86 percent in the 2024 study. The shift is unsurprising. Done right, digital validation delivers speed to market; trustworthy, scalable compliance; and a foundation to leverage integrated automation and AI-driven innovations in the future. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. Cautionary and Forward-Looking Statements Except for the statements of historical fact contained herein, certain information presented constitutes 'forward-looking information' within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, and the compliance of Kneat's platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties. Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor's own risk. For more information visit Contact: Katie Keita, Kneat Investor RelationsP: + 1 902-450-2660 E: investors@ in to access your portfolio
Yahoo
28-05-2025
- Business
- Yahoo
Kneat Announces Results of Voting at Annual General Meeting
LIMERICK, Ireland, May 28, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTC: KSIOF) ("Kneat" or the "Company") a leader in digitizing and automating validation processes, announced results from its Annual General Meeting of Shareholders (the "2025 AGM"), which took place today. All director nominees were elected to the board of directors (the "Kneat Board") and KPMG LLP was appointed as auditors, as further described in the related Management Information Circular dated April 23, 2025 (the "Circular"). The detailed results of voting at the 2025 AGM are set out below: 1. Election of Directors Shareholders voted to elect all five directors nominated to the Kneat Board. Name of Nominee Number of Votes Cast Votes "For" Votes "For" % Ian Ainsworth 48,954,620 47,616,238 97.27% Edmund Ryan 48,954,620 48,954,095 100.00% Wade K. Dawe 48,954,620 47,008,047 96.02% Nutan Behki 48,954,620 47,644,301 97.32% Carol Leaman 48,954,620 48,939,765 99.97% 2. Re-Appointment of Auditors Shareholders voted to approve management's recommendation that KPMG LLP be re-appointed as auditors of the Company, to hold office until the close of the next annual meeting of shareholders, and to authorize the Company to fix their remuneration for the forthcoming year. Number of Votes Cast Votes "For" Votes "For" % 48,954,620 48,908,449 99.91% Final voting results on all matters voted at the 2025 AGM have been filed with Canadian securities regulators. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end to end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. For further information: Katie Keita, Kneat Investor RelationsP: + 1 902-706-9074E: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-05-2025
- Business
- Yahoo
Global Diagnostics Leader Selects Kneat
LIMERICK, Ireland, May 15, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of clinical diagnostics for the healthcare industry ('the Company') has signed a three-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, operates in more than 40 countries and employs over 14,000 people, provides a comprehensive range of clinical diagnostics and biomedical testing for the healthcare industry. Its diagnostic solutions are used by hospitals, laboratories and physicians' offices around the world for routine and complex clinical testing. As a division of a larger life sciences organization with more than 60,000 employees, the Company will use Kneat Gx initially to digitize its equipment validation process. 'The quality of our platform, its maturity in the market and the expertise and commitment of our team enabled this win,' said Eddie Ryan, Kneat's CEO. 'Adopting Kneat is another step in this customer's longstanding commitment to continuous improvement. We look forward to working with them to deliver the efficiency and compliance benefits that characterize Kneat.' As the many segments of life sciences seek to improve quality, compliance and speed to market, more and more companies are shifting from a manual, paper-based validation process to one that is streamlined and harmonized through digitalization. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. Cautionary and Forward-Looking Statements Except for the statements of historical fact contained herein, certain information presented constitutes 'forward-looking information' within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, and the compliance of Kneat's platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties. Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor's own risk. For more information visit For further information: Katie Keita, Kneat Investor RelationsP: + 1 902-450-2660 E: investors@
Yahoo
15-05-2025
- Business
- Yahoo
Global Diagnostics Leader Selects Kneat
LIMERICK, Ireland, May 15, 2025 (GLOBE NEWSWIRE) -- inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of clinical diagnostics for the healthcare industry ('the Company') has signed a three-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, operates in more than 40 countries and employs over 14,000 people, provides a comprehensive range of clinical diagnostics and biomedical testing for the healthcare industry. Its diagnostic solutions are used by hospitals, laboratories and physicians' offices around the world for routine and complex clinical testing. As a division of a larger life sciences organization with more than 60,000 employees, the Company will use Kneat Gx initially to digitize its equipment validation process. 'The quality of our platform, its maturity in the market and the expertise and commitment of our team enabled this win,' said Eddie Ryan, Kneat's CEO. 'Adopting Kneat is another step in this customer's longstanding commitment to continuous improvement. We look forward to working with them to deliver the efficiency and compliance benefits that characterize Kneat.' As the many segments of life sciences seek to improve quality, compliance and speed to market, more and more companies are shifting from a manual, paper-based validation process to one that is streamlined and harmonized through digitalization. About Kneat Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard. Cautionary and Forward-Looking Statements Except for the statements of historical fact contained herein, certain information presented constitutes 'forward-looking information' within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization, and the compliance of Kneat's platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties. Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor's own risk. For more information visit For further information: Katie Keita, Kneat Investor RelationsP: + 1 902-450-2660 E: investors@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
